2021
DOI: 10.3390/ma14071810
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Histomorphometric and Micromorphometric Performance of a Serum Albumin-Coated Bone Allograft Combined with A-PRF for Early and Conventional Healing Protocols after Maxillary Sinus Augmentation: A Randomized Clinical Trial

Abstract: The aim of this study was to compare the microarchitecture of augmented bone following maxillary sinus augmentation (MSA) after healing periods of 3 (test) and 6 (control) months using the combination of advanced platelet-rich fibrin (A-PRF) and a serum albumin-coated bone allograft (SACBA). Twenty-six patients with 30 surgical sites who required two-stage MSA were enrolled and grafted with the combination of A-PRF and SACBAs. The surgical sites were randomly allocated to the test or control group. During impl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 51 publications
(36 reference statements)
0
6
0
2
Order By: Relevance
“…The newly formed bone at 4 months after MSFA using DBB with leukocytes and PRF was significantly greater than at 8 months after MSFA using DBB only [ 36 ]. Similarly, with the use of advanced PRF, no significant differences were observed in bone healing at the implant site and in implant stability between the healing periods of 3 months after MSFA and 6 months after MSFA [ 37 ]. In addition, heterologous bioactive proteins, such as recombinant human platelet-derived growth factor and rhBMPs, were also evaluated for potential in enhanced bone healing after MSFA [ 31 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…The newly formed bone at 4 months after MSFA using DBB with leukocytes and PRF was significantly greater than at 8 months after MSFA using DBB only [ 36 ]. Similarly, with the use of advanced PRF, no significant differences were observed in bone healing at the implant site and in implant stability between the healing periods of 3 months after MSFA and 6 months after MSFA [ 37 ]. In addition, heterologous bioactive proteins, such as recombinant human platelet-derived growth factor and rhBMPs, were also evaluated for potential in enhanced bone healing after MSFA [ 31 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, the stability of both PRF alone and PRF composites at long term studies are still unknown (79). Besides, advanced platelet-rich fibrin (A-PRF) and Leukocyte-platelet-rich fibrin (L-PRF) also have been used widely for bone tissue engineering (81)(82)(83)(84)(85)(86)(87). Fig.…”
Section: Development Of Fibrin Composite In Mimicking Bone Tissuementioning
confidence: 99%
“…Alkalmazásával elkerülhető a sebgyógyulás zavara, továbbá a relapsusok aránya is jelentősen csökkent [26,27]. Kimutatták, hogy a PRF újabb generációjának (advanced PRF -A-PRF) csontpótlóval történő együttes alkalmazása csökkentheti a sinus maxillaris augmentációt követő implantációhoz szükséges gyógyulási időt [28].…”
Section: Rövidítésekunclassified